Search     Contact 
     Members Sign-in 
ABOUT BAYBIOGET INVOLVEDEVENT CENTERMEMBER CENTERINFORMATION CENTERMEDIA CENTER



CAREER CENTER

 

BayBio Successfully Launches BayBio:IMPACT 2010

January 12, 2010 - Despite historic economic woes, California’s life sciences industry’s output was greater than ever before. The number of treatments, technologies and devices available to patients increased 35 percent in 2009 as compared to 2008. In total, there are 1,754 marketed products available to patients, doctors and clinics worldwide that have California origins, according to data released today by BayBio during the launch of the flagship industry study BayBio: IMPACT 2010




Partners

Alexandria Real Estate Equities Amgen Baxter BioMed Reality Trust, Inc.
Biospace Burr Pilger Mayer Burrill and Company Cooley Godward Kronish
Deloitte Touche Tohmatsu DLA Piper Ernest & Young FedEx
Fenwick & West Genencor International Genentech Gilead
King & Spalding KPMG Latham and Watkins Morrison & Foerster
Nektar Oracle Life Sciences PCW Roche
RoseRyan Wells Fargo Technology Vision Group VWR
Wareham Development Wells Fargo

BayBio 400 Oyster Point Blvd. Suite 221 South San Francisco CA 94080 Tel: (650) 871-7101